Earnings News - Candlesense

1-800-FLOWERS.COM, Inc. to Release its Fiscal 2025 Fourth Quarter and Year End Results on Thursday, September 4, 2025

JERICHO, N.Y.--(BUSINESS WIRE)--1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS) (the “Company”), a leading provider of thoughtful expressions designed to help inspire customers to give more, connect more, a...

Did the earnings call reveal any risks or opportunities—such as supply‑chain constraints, labor shortages, or new partnership initiatives—that could affect the stock’s volatility? What was the performance of the company's international operations, and are there any expansion or divestiture plans that could affect the balance sheet? Are there any notable shifts in the company's product mix or channel strategy (e.g., increased digital or subscription offerings) that could influence future growth?

Symbol: FLWS

26 days ago

Read more businesswire

PVH Corp. to Host Conference Call to Discuss Second Quarter 2025 Earnings Results

NEW YORK--(BUSINESS WIRE)--PVH Corp. (NYSE: PVH) today announced that it will release its second quarter 2025 earnings results on Tuesday, August 26, 2025, after the market closes. PVH will sponsor...

Did the CFO address any changes in operating cash flow or liquidity that could affect the company's financial stability? Are there any macroeconomic or consumer sentiment factors highlighted that could impact future performance? What capital allocation plans (e.g., share buybacks, dividends, debt repayment) were discussed during the call?

Symbol: PVH

26 days ago

Read more businesswire

MIND CTI Reports Second Quarter 2025 Results

YOQNEAM, Israel, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MIND C.T.I. LTD. – (NasdaqGM:MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product-based solutio...

How might this earnings release influence the stock's short‑term price movement and trading volume? What is the impact of any macro‑economic factors or regulatory developments on the company's performance? Did the company announce any new product launches, partnerships, or contracts that could impact future growth?

Symbol: MNDO

26 days ago

Read more globenewswire

AITX Extinguishes Almost $5 Million of Debt, Targets FY Q2 Profit

Strategic Debt Settlement Bolsters Balance Sheet; Company on Track to Report Net Profitability for Q2 FY 2026

How does the debt reduction influence the company's strategic growth initiatives or M&A opportunities? What is the anticipated effect on AITX's credit rating and borrowing costs moving forward? How might the market react to the earnings guidance and debt settlement news in the short term?

Symbol: AITX

26 days ago

Read more globenewswire

Sonida Senior Living Announces Second Quarter 2025 Results

DALLAS--(BUSINESS WIRE)---- $SNDA--Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, tod...

What potential regulatory or market developments could impact Sonida's ability to maintain or expand its portfolio performance? How could macro factors such as interest rates, inflation, and senior housing demand affect the sustainability of Sonida's rent growth? Are there any forward‑looking guidance updates or changes in the company's capital allocation strategy following this release?

Symbol: SNDA

26 days ago

Read more businesswire

MeridianLink Reports Second Quarter 2025 Results

IRVINE, Calif.--(BUSINESS WIRE)---- $MLNK #digitallending--MeridianLink today announced financial results for the second quarter ended June 30, 2025.

Did the earnings call reveal any management commentary on risk factors or regulatory changes that could affect the business? What is the cash flow situation, including operating cash flow and capital expenditures, and does it affect the company's liquidity outlook? Are there any macroeconomic factors (e.g., interest rates, housing market trends) that could influence the company's future performance?

Symbol: MLNK

26 days ago

Read more businesswire

Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, ...

Are there any indications of upcoming product launches or market expansions that could impact long‑term growth? What potential catalysts or risks could drive the stock price in the short term following this release? How does Protara's Q2 performance and pipeline outlook compare to its main competitors in the oncology and rare disease space?

Symbol: TARA

26 days ago

Read more globenewswire

ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025

UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced tod...

Will the Q2 results lead to any adjustments in short‑term trading strategies or position sizing for PRPH? Did the management address any macroeconomic or supply chain risks that could influence the company's outlook? What was the market's reaction to the earnings call and are there any notable shifts in institutional sentiment?

Symbol: PRPH

26 days ago

Read more globenewswire

Bit Digital, Inc. Announces Date for Second Quarter 2025 Financial Results and Conference Call

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Bit Digital, Inc. (Nasdaq: BTBT) ("Bit Digital" or the "Company"), in New York, announced today that it will release its Second Quarter 2025 results on Thurs...

How might the Q2 results influence short‑term technical patterns and the positioning of institutional versus retail investors? Are there any risks or red‑flags (e.g., higher operating costs, equipment shortages) that could lead to a negative price reaction? Could the timing of the results release after market close affect after‑hours trading dynamics and liquidity?

Symbol: BTBT

26 days ago

ArriVent BioPharma Reports Second Quarter 2025 Financial Results

NEWTOWN SQUARE, Pa., Aug. 11, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of ...

What market reaction has the press release generated so far, and are there any notable changes in trading volume or price volatility? How does the reported performance impact the company's competitive positioning within its therapeutic area? What are the potential regulatory or FDA filing timelines for its lead candidates, and what risks are associated with them?

Symbol: AVBP

26 days ago

Read more globenewswire